EnChannel Medical

About EnChannel Medical

EnChannel Medical is dedicated to redefining electrophysiology with innovative technologies like the DePolar™ mapping system and NanoAblate™ PFA platform. Their mission is to enhance the quality of life for heart rhythm patients through discerning technology and a passion for innovation, leading to enduring outcomes.

Products & Services

DePolar™ Mapping System:A next-generation system offering integrated contact and noncontact mapping for electrophysiology.

NanoAblate™ PFA Platform:A novel 3rd generation pulsed field ablation technology with single-shot and large-focal catheter morphologies.

Navigation Solutions:Hybrid magnetic and impedance navigation systems for precise electrophysiology procedures.

Advanced Algorithms:Modern AI-based algorithms to enhance electrophysiology solutions.

Specialties

Electrophysiology Cardiac Mapping Pulsed Field Ablation AI-based Algorithms Navigation Systems

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 82200000 MR: - FA: $82.2M FAN: 82200000	D: 2025-05-01 FD: 2025-05-01	3 investors

Series B Latest

2025-05-01

$82.2M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

J

Jun Feng

Chief Executive Officer, Co-Founder

M

Min Zhu

Chief Technology Officer, Co-Founder

G

Graydon Beatty

Chief Science Officer, Co-Founder

Recent News